在儿科中,严重和不严重的登革热之间的临床和实验室特征的比较
Nurul Liyana Idrus1,2, Shamsuriani Md Jamal1, Afliza Abu Bakar1
1Department of Emergency Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur, Malaysia.
PLoS neglected tropical diseases
|December 19, 2023
概括
在儿童中早期发现严重的登革热至关重要. 疲,低血压,长时间的毛细血管充满时间,,肝是儿童登革热病例及时诊断和干预的关键指标.
科学领域:
- 儿童传染病 儿童传染病
- 临床医学 临床医学
- 流行病学 流行病学
背景情况:
- 及时识别儿童严重登革热至关重要,以防止冲击和致命的结果.
- 儿童登革热的延迟诊断可能导致不可逆转的并发症.
- 在急诊室了解严重登革热的早期指标至关重要.
研究的目的:
- 在儿科患者中描述登革热的严重程度.
- 识别与严重登革热相关的初始症状,迹象和实验室发现.
- 改善儿童严重登革热的早期诊断和管理.
主要方法:
- 对254例确诊的儿科登革热病例的医疗记录进行了回顾性分析.
- 严重和不严重的登革热组之间的临床特征的比较.
- 后勤回归分析以确定与严重登革热相关的变量.
主要成果:
- 15.4%的儿科患者 (39/254) 被诊断出患有严重的登革热.
- 麻,缩血压<90 mmHg,毛细血管补充时间>2秒,风和肝壮病独立地与严重的登革热有关.
- 这些临床指标是儿童严重登革热的重要预测因素.
结论:
- 在儿童中,严重的登革热表现出特定的临床指标:昏迷,低血压,长时间的CRT,,肝炎.
- 初级保健医生早期识别这些特征对于及时干预至关重要.
- 严重的儿科登革热的有效管理依赖于基于这些临床症状的及时诊断.
相关概念视频
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...


